1. Homepage
  2. Equities
  3. Belgium
  4. Euronext Bruxelles
  5. Celyad Oncology SA
  6. Consensus
    CYAD   BE0974260896

CELYAD ONCOLOGY SA

(CYAD)
  Report
Real-time Quote. Real-time Euronext Bruxelles - 05/16 03:00:21 am
1.604 EUR   -2.20%
05/06Celyad Oncology SA Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/05CELYAD ONCOLOGY SA : 1st quarter results
CO
05/05CELYAD ONCOLOGY SA : Proxy Statments
CO
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Evolution of the average Target Price on CELYAD ONCOLOGY SA
Target Price consensus revisions : last 18 months
Recommendations (Chart) CELYAD ONCOLOGY SA
Analyst Recommendations on CELYAD ONCOLOGY SA
02/28HC Wainwright Downgrades Celyad Oncology Neutral From Buy, Shares Plunge 12% at Midday Tra..
MT
01/11Wells Fargo Adjusts Celyad Oncology's Price Target to $11 from $20, Keeps Overweight Ratin..
MT
2021CELYAD ONCOLOGY : HC Wainwright Adjusts Celyad Oncology's Price Target to $15 From $17, Maintains Buy Rating
MT
2021CELYAD ONCOLOGY : JonesTrading Downgrades Celyad Oncology to Hold from Buy
MT
2020CELYAD ONCOLOGY : HC Wainwright Adjusts Celyad Oncology's Price Target to $18 From $22, Keeps Buy Rating
MT
More recommendations
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Last Close Price 1,64 €
Average target price 11,00 €
Spread / Average Target 571%
High Price Target 11,00 €
Spread / Highest target 571%
Low Price Target 11,00 €
Spread / Lowest Target 571%
Consensus detail
Consensus revision (last 18 months)